{"id":"W2291152756","doi":"10.1016/s2352-3026(16)00004-1","title":"Pharmacokinetics, safety, and efficacy of subcutaneous versus intravenous rituximab plus chemotherapy as treatment for chronic lymphocytic leukaemia (SAWYER): a phase 1b, open-label, randomised controlled non-inferiority trial","year":2016,"lang":"en","type":"article","venue":"The Lancet Haematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Medicine; Rituximab; Fludarabine; Clinical endpoint; Cyclophosphamide; Pharmacokinetics; Population; Internal medicine; Clinical trial; Surgery; Chemotherapy; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009876386,0.000483126,0.004189887,0.0001222548,0.0001878817,0.00004300229,0.0006493144,0.000267875,0.0002305945],"category_scores_gemma":[0.0009918149,0.0002629609,0.0002316811,0.000169403,0.0008318187,0.00006555094,0.0001917445,0.0001743784,0.00004914332],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.01565166,"about_ca_system_score_gemma":0.01428438,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000581543,"about_ca_topic_score_gemma":0.00007900969,"domain_scores_codex":[0.9966336,0.0003483552,0.001012618,0.0006520397,0.0003564071,0.0009969204],"domain_scores_gemma":[0.9925575,0.005542221,0.0004429483,0.001015328,0.0002072098,0.0002347688],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9560397,0.001973825,9.409227e-7,0.0002969567,0.001403518,0.0006894276,0.0004652994,0.000007594952,0.007175419,0.0006229462,0.0004842027,0.03084012],"study_design_scores_gemma":[0.9484953,0.01949366,0.000001189473,0.0001753358,0.00107551,0.003011767,0.00002605565,0.01085116,0.01295117,0.0001977838,0.003453463,0.000267582],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.97641,0.002087906,0.0006491348,0.003653086,0.000612435,0.01547098,0.00008362078,0.0000736325,0.0009592324],"genre_scores_gemma":[0.9907143,0.006142289,0.0002987759,0.0003371902,0.0008809124,0.0009052402,0.00003104452,0.00008141665,0.0006089055],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03057254,"threshold_uncertainty_score":0.9999822,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06490262390275962,"score_gpt":0.4059350666630088,"score_spread":0.3410324427602492,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}